AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
St. Jude to manufacture investigative drugs and vaccines.
2003 MAY 14 - (NewsRx.com & NewsRx.net) -- St. Jude Children's Research Hospital has become the only pediatric cancer research center in the United States to open a Good Manufacturing Practices (GMP) facility for producing vaccines, drugs, proteins, gene-based molecules, and other biological products.
The facility also has Biological Safety Level (BSL) three laboratories to accommodate work with microorganisms that must be specially contained.
The GMP facility, which meets standards of operation established by the U.S. Food and Drug Administration (FDA), will allow the research center to produce such products as the three-tiered AIDS vaccine currently under development at St. Jude, as well as a cholera virus, vaccines for influenza and parainfluenza, immunotherapy proteins and other drugs and diagnostic products.
The facility is designed to support the hospital's goal of swiftly taking research from the laboratory to the clinic. The GMP facility's mission is to solve the problem of how to engage major pharmaceutical companies that are reluctant to make a large up-front investment in developing products that will have a limited market.
"The GMP facility will be key to our strategy of fast-tracking breakthroughs in basic ...
- Karolinska Development Portfolio Company Launches GMP Facility for Particulate...
- Newspaper article from: Biotech Week September 9, 2009 700+ words
...As well as offering all the advantages of earlier supercritical fluid technologies it is also fully scalable. The new GMP facility has been developed in collaboration with Galenica AB, an established Swedish CRO focused on pharmaceutical formulation...
- Maryland GMP facility to offer training to FDA inspectors, industry.(Training)
- Newspaper article from: Validation Times Reid, Ken May 1, 2004 700+ words
WASHINGTON -- The University of Maryland Biotechnology Institute (UMBI), Baltimore, plans to open a 15,000-square-foot pilot biotech facility in August 2004, for use in training FDA inspectors and industry personnel. Addressing the annual FDA Science Forum here May 19, Claude Nash, Ph.D., vice
- Cytos builds GMP facility.(pharmaceuticals & fine chemicals)(Genetically...
- Magazine article from: Chemical Week September 1, 2004 700+ words
Cytos Biotech (Schlieren, Switzerland) says it has begun building a cGMP facility for clinical-trial production of biologic drugs at Schlieren. The facility will include a 50-liter fermentation tank, and is due to come online by the start of 2005. Cytos says it will switch operations to the planned
- DURA PHARMACEUTICALS ANNOUNCES PLANS TO BUILD OUT GMP FACILITY AND INITIATES...
- Press release article from: PR Newswire February 14, 1994 700+ words
...conditions. -0- 2/14/94 /CONTACT: Cam L. Garner, president and CEO, of Dura Pharmaceuticals, 619-457-2553/ (DURA) CO: Dura Pharmaceuticals Inc. ST: California IN: MTC SU: JM-JB -- SD006 -- 2690 02/14/94 08:35 EST
- GUILFORD PHARMACEUTICALS CLOSES ON $8 MILLION BOND OFFERING
- Press release article from: PR Newswire December 12, 1994 700+ words
...Guilford to begin construction of its GMP facility for the manufacture of GLIADEL...the Company expects to complete its GMP facility for GLIADEL(R) by early 1995...Guilford Pharmaceuticals, Inc. ST: Maryland IN: MTC SU: OFR LG...
- Bio-Bridge Science Signs a Non-Binding MOU to form a Joint Venture in China.
- Press release article from: Business Wire April 16, 2008 700+ words
...future as the demand for bovine serum increases. Beijing GMP Facility Completion Update Bio-Bridge signed a contract in March...and the electricity construction work for Bio-Bridge's GMP facility in Tianzho (Beijing) is currently underway. Bio-Bridge...
- Signet Laboratories Adds Two Key Executives; Pioneer in evidence-based medicine...
- Press release article from: PR Newswire September 1, 2004 700+ words
...will assume strategic and tactical leadership of Signet's GMP facility, its Production and Development team, and Manufacturing...detection products and accessories in an FDA registered GMP facility. Signet products are available online, at http://www...
- Bio-Bridge Science Issues Corporate Update.
- Press release article from: Business Wire June 19, 2007 700+ words
...encouraging results. After the vaccine samples are produced in our GMP facility in Beijing, we will submit application for clinical trials...Facility Completion Update The electricity project for our GMP facility in Beijing is in process and the Company expects the project...
Source: HighBeam Research, St. Jude to manufacture investigative drugs and vaccines.